DISHMAN CARBOGEN AMCIS LTD.

NSE : DCALBSE : 540701ISIN CODE : INE385W01011Industry : Pharmaceuticals & DrugsHouse : Dishman Pharma
BSE166.95-0.6 (-0.36 %)
PREV CLOSE ( ) 167.55
OPEN PRICE ( ) 166.00
BID PRICE (QTY) 166.50 (329)
OFFER PRICE (QTY) 166.90 (59)
VOLUME 10774
TODAY'S LOW / HIGH ( )163.85 167.40
52 WK LOW / HIGH ( )129 321.15
NSE166.77-0.72 (-0.43 %)
PREV CLOSE( ) 167.49
OPEN PRICE ( ) 167.49
BID PRICE (QTY) 166.70 (63)
OFFER PRICE (QTY) 166.98 (6)
VOLUME 75033
TODAY'S LOW / HIGH( ) 163.57 168.08
52 WK LOW / HIGH ( )128.5 321.95
Exchange
Period From    
Period To    
Exchange Deal Date Client Name Tran Qty (000's) Trade Price () Value (Rs.in Lakhs) Close Price ()

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.